GSK (NYSE: GSK) sets total voting rights at 4.06B shares

Rhea-AI Filing Summary

GSK plc reported its total voting rights as of 31 March 2026. The company had 4,316,179,781 issued ordinary shares of 31 ¼ pence each, with 256,112,615 shares held in treasury. This leaves 4,060,067,166 voting rights, which shareholders can use as the denominator for disclosure threshold calculations under UK transparency rules.

Key Figures

Issued share capital: 4,316,179,781 ordinary shares Treasury shares: 256,112,615 ordinary shares Total voting rights: 4,060,067,166 +1 more

4 metrics

Issued share capital 4,316,179,781 ordinary shares Issued share capital as at 31 March 2026

Treasury shares 256,112,615 ordinary shares Held in treasury as at 31 March 2026

Total voting rights 4,060,067,166 Shares with voting rights as at 31 March 2026

Nominal value per share 31 ¼ pence per share Ordinary shares nominal value

Key Terms

Total Voting Rights, Treasury, Disclosure Guidance and Transparency Rule 5.6.1R, voting rights, +1 more

5 terms

Total Voting Rights financial

"Total Voting Rights In conformity with the Financial Conduct Authority's Disclosure Guidance"

The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.

Treasury financial

"of which 256,112,615 Ordinary Shares were held in Treasury."

The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.

Disclosure Guidance and Transparency Rule 5.6.1R regulatory

"In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R"

voting rights financial

"Therefore, the total number of voting rights in the Company is 4,060,067,166."

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

Financial Conduct Authority regulatory

"In conformity with the Financial Conduct Authority's Disclosure Guidance"

A government-authorized regulator that sets and enforces rules for banks, brokers, insurers and other financial firms to keep markets fair and safe. Think of it as a referee for the financial system: it watches for cheating, protects consumers, and can penalize companies that break the rules. Its actions matter to investors because enforcement decisions, rule changes or approvals influence company costs, reputations and overall market confidence.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

Issued: 1 April 2026, London UK

Total Voting Rights

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 March 2026 consisted of 4,316,179,781 shares of 31 ¼ pence each ('Ordinary Shares'), of which 256,112,615 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,060,067,166. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com.

V A Whyte

Company Secretary

1 April 2026

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: April 01, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What total voting rights did GSK (GSK) report as of 31 March 2026?

GSK reported a total of 4,060,067,166 voting rights as of 31 March 2026. Shareholders can use this figure as the denominator when assessing whether they must notify holdings under the UK Disclosure Guidance and Transparency Rules.

How many GSK (GSK) shares were in issue and in treasury at 31 March 2026?

GSK’s issued share capital comprised 4,316,179,781 ordinary shares of 31 ¼ pence each at 31 March 2026. Of these, 256,112,615 shares were held in treasury, meaning they do not carry voting rights while in treasury.

Why is GSK (GSK) publishing a total voting rights figure?

GSK publishes its total voting rights to comply with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rule 5.6.1R. This helps investors determine when their shareholding crosses regulatory thresholds that require notification of interests or changes in interests.

Which shares count towards voting rights for GSK (GSK) shareholders?

Only shares not held in treasury count towards voting rights. For GSK, 4,060,067,166 shares carried voting rights at 31 March 2026, while 256,112,615 treasury shares were excluded from this total and do not vote while held in treasury.

How can GSK (GSK) shareholders notify the company of major holdings changes?

Shareholders can send major holdings notifications to GSK by email at company.secretary@gsk.com. These notifications are required when holdings cross relevant thresholds under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules in the United Kingdom.